Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants

Vaccine

Volumn 17, Issue 15-16, 1999, Pages 1910-1918

  Pabst, Henry F ^a   Spady, Donald W ^a   Carson, Mary M ^a   Krezolek, Margaret P ^a   Barreto, Louis ^b   Wittes, Robert C ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Pasteur Merieux Connaught Canada   (Canada)

Author keywords

Infants; Measles vaccination; T and B immunity

Indexed keywords

MEASLES VACCINE; TETANUS TOXOID; VIRUS VACCINE;

ARTICLE; CELLULAR IMMUNITY; CHILDHOOD DISEASE; HUMAN; HUMORAL IMMUNITY; INFANT; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS INFECTION;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; B-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; INFANT; INTERFERON TYPE II; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MEASLES; MEASLES VACCINE; MEASLES VIRUS; MOTHERS; T-LYMPHOCYTES; VACCINATION;

EID: 0033538039     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00472-1     Document Type: Article

References (16)

1. Carson M.M., Spady D.W., Albrecht P.et al. Measles vaccination of infants in a well vaccinated population. Pediatr. Infect. Dis. J. 14:1995;17-22.
2. Gindler J.S., Atkinson W.L., Markowitz L.E., Hutchins S.S. Epidemiology of measles in the United States in 1989 and 1990. Pediatr. Infect. Dis. J. 11:1992;841-846.
3. Aaby P., Andersen M., Knudsen K. Excess mortality after early exposure to measles. Int. J. Epidemiol. 22:1993;156-162.
4. Bolotovski V.M., Grabowsky M., Clements C.J.et al. Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine. Int. J. Epidemiol. 23:1994;1069-1077.
5. Zinkernagel R.M. Immunology taught by viruses. Science. 271:1996;173-178.
6. Pabst H.F., Spady D.W., Carson M.M., Stelfox H.T., Beeler J.A., Krezolek M.P. Kinetics of immunologic responses after primary MMR vaccination. Vaccine. 15:1997;10-14.
7. Pabst H.F., Spady D.W., Marusyk R.G.et al. Reduced measles immunity in infants in a well-vaccinated population. Pediatr. Infect. Dis. J. 11:1992;525-529.
8. Schwarzer S., Reibel S., Lang A.B.et al. Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines. Vaccine. 16:1998;298-304.
9. Surcel H.M., Troye-Blomberg M., Paulie S.et al. Th1/Th2 profiles in tuberculosis based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology. 81:1994;171-176.
10. Miller C., Farrington C.P., Harbert K. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989. Int. J. Epidemiol. 21:1992;998-1006.
11. Dorian B., Garfinkel P., Brown G., Shore A., Gladman D., Keystone E. Aberrations in lymphocyte subpopulations and function during psychological stress. Clin. Exp. Immunol. 50:1982;132-138.
12. Husband A.J. Role of central nervous system and behaviour in the immune response. Vaccine. 11:1993;805-816.
13. Ader R., Cohen N., Felten D. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet. 345:1995;99-103.
14. Samb B., Aaby P., Whittle H.C.et al. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatr. Infect. Dis. J. 14:1995;203-209.
15. Chen R.T., Markowitz L.E., Albrecht P.et al. Measles antibody: reevaluation of protective titers. J. Inf. Dis. 162:1990;1036-1042.
16. Mathias R.G., Meekison W.G., Arcand T.A., Schechter M.T. The role of secondary vaccine failures in measles outbreaks. Am. J. Public Health. 79:1989;475-478.